Literature DB >> 31751178

Salivary antimicrobial proteins and stress biomarkers are elevated during a 6-month mission to the International Space Station.

Nadia H Agha1, Forrest L Baker1,2,3, Hawley E Kunz1,4, Guillaume Spielmann1,5, Preteesh L Mylabathula1,2,3, Bridgette V Rooney1,6, Satish K Mehta7, Duane L Pierson8, Mitzi S Laughlin1,9, Melissa M Markofski1, Brian E Crucian8, Richard J Simpson1,2,3,10,11.   

Abstract

As the international space community plans for manned missions to Mars, spaceflight-associated immune dysregulation has been identified as a potential risk to the health and safety of the flight crew. There is a need to determine whether salivary antimicrobial proteins, which act as a first line of innate immune defense against multiple pathogens, are altered in response to long-duration (>6 mo) missions. We collected 7 consecutive days of whole and sublingual saliva samples from eight International Space Station (ISS) crewmembers and seven ground-based control subjects at nine mission time points, ~180 and ~60 days before launch (L-180/L-60), on orbit at flight days ~10 and ~90 (FD10/FD90) and ~1 day before return (R-1), and at R+0, R+18, R+33, and R+66 days after returning to Earth. We found that salivary secretory (s)IgA, lysozyme, LL-37, and the cortisol-to-dehydroepiandrosterone ratio were elevated in the ISS crew before (L-180) and during (FD10/FD90) the mission. "Rookie" crewmembers embarking on their first spaceflight mission had lower levels of salivary sIgA but increased levels of α-amylase, lysozyme, and LL-37 during and after the mission compared with the "veteran" crew who had previously flown. Latent herpesvirus reactivation was distinct to the ~6-mo mission crewmembers who performed extravehicular activity ("spacewalks"). Crewmembers who shed at least one latent virus had higher cortisol levels than those who did not shed. We conclude that long-duration spaceflight alters the concentration and/or secretion of several antimicrobial proteins in saliva, some of which are related to crewmember flight experience, biomarkers of stress, and latent viral reactivation.NEW & NOTEWORTHY Spaceflight-associated immune dysregulation may jeopardize future exploration-class missions. Salivary antimicrobial proteins act as a first line of innate immune defense. We report here that several of these proteins are elevated in astronauts during an International Space Station mission, particularly in those embarking on their first space voyage. Astronauts who shed a latent herpesvirus also had higher concentrations of salivary cortisol compared with those who did not shed. Stress-relieving countermeasures are needed to preserve immunity and prevent viral reactivation during prolonged voyages into deep space.

Entities:  

Keywords:  astronauts; herpesvirus; immunology; latent viral reactivation; spaceflight

Mesh:

Substances:

Year:  2019        PMID: 31751178      PMCID: PMC7864226          DOI: 10.1152/japplphysiol.00560.2019

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  51 in total

1.  Incidence of Epstein-Barr virus in astronaut saliva during spaceflight.

Authors:  D A Payne; S K Mehta; S K Tyring; R P Stowe; D L Pierson
Journal:  Aviat Space Environ Med       Date:  1999-12

Review 2.  Antimicrobial agents in saliva--protection for the whole body.

Authors:  Jorma Tenovuo
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

Review 3.  Sick and tired: Does sleep have a vital role in the immune system?

Authors:  Penelope A Bryant; John Trinder; Nigel Curtis
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

Review 4.  Blood contamination in salivary diagnostics: current methods and their limitations.

Authors:  Jeong-Hyun Kang; Hong-Seop Kho
Journal:  Clin Chem Lab Med       Date:  2019-07-26       Impact factor: 3.694

5.  Direct inactivation of viruses by human granulocyte defensins.

Authors:  K A Daher; M E Selsted; R I Lehrer
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro.

Authors:  A Bastian; H Schäfer
Journal:  Regul Pept       Date:  2001-09-15

7.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

8.  Multiple latent viruses reactivate in astronauts during Space Shuttle missions.

Authors:  S K Mehta; M L Laudenslager; R P Stowe; B E Crucian; C F Sams; D L Pierson
Journal:  Brain Behav Immun       Date:  2014-06-02       Impact factor: 7.217

Review 9.  Epithelial antimicrobial peptides in host defense against infection.

Authors:  R Bals
Journal:  Respir Res       Date:  2000-10-20

10.  Alterations in adaptive immunity persist during long-duration spaceflight.

Authors:  Brian Crucian; Raymond P Stowe; Satish Mehta; Heather Quiriarte; Duane Pierson; Clarence Sams
Journal:  NPJ Microgravity       Date:  2015-09-03       Impact factor: 4.415

View more
  3 in total

1.  One Year in the Extreme Isolation of Antarctica-Is This Enough to Modulate an "Allergic" Sensitization?

Authors:  Matthias Feuerecker; Claudia Strewe; Martina Aumayr; Tim Heitland; Ulrich Limper; Brian Crucian; Sarah Baatout; Alexander Choukér
Journal:  Biomedicines       Date:  2022-02-15

Review 2.  The Future of Personalized Medicine in Space: From Observations to Countermeasures.

Authors:  Elizabeth Pavez Loriè; Sarah Baatout; Alexander Choukér; Judith-Irina Buchheim; Bjorn Baselet; Cinzia Dello Russo; Virginia Wotring; Monica Monici; Lucia Morbidelli; Dimitri Gagliardi; Julia Caroline Stingl; Leonardo Surdo; Vincent Lai Ming Yip
Journal:  Front Bioeng Biotechnol       Date:  2021-12-13

3.  Salivary Biomarkers and Work-Related Stress in Night Shift Workers.

Authors:  Giusi Briguglio; Michele Teodoro; Sebastiano Italia; Francesca Verduci; Manuela Pollicino; Manuela Coco; Annalisa De Vita; Elvira Micali; Angela Alibrandi; Giuseppe Lembo; Chiara Costa; Concettina Fenga
Journal:  Int J Environ Res Public Health       Date:  2021-03-19       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.